Results
Ind-Swift Laboratories Q2 Revenue Up 50%, PAT Surges 3.5x
Ind-Swift Laboratories reported unaudited Q2 FY27 standalone revenue growth of 50.15% to ₹234.89 crore.
Operating EBITDA surged 4.95x to ₹42.33 crore with margin expanding 1,256 basis points to 18.02%
